INTRODUCTION
MAGNESIUM depletion in man can occur associated with primary aldosteronism, prolonged or severe fluid loss, diuretic therapy, alcoholism, hypercalcaemia, malabsorption, or following the removal of a parathyroid adenoma (Fraser & McIntyre, 1970) . The symptoms of pure magnesium deficiency may include depression, irritability, aggressiveness, disorientation, hallucinations, vertigo, ataxia, tremor, epileptiform convulsions and muscular weakness (Hanna et al., 1960; Smith, 1963) .
Broughton et al. (1968) observed hypomagnesaemia in eight out of 20 patients with burns. Five of the eight exhibited symptoms of magnesium deficiency and it was thought that this state may have been associated with secondary hyper aldosteronism. Paraplegic patients were observed to have an increased urinary magnesium 1-2 weeks after onset (R. G. Burr, unpublished observations), and in view of the occasional appearance among acute paraplegics of psychiatric symptoms resembling those of magnesium deficiency (J. J. Walsh, Personal communication) it was decided to examine the possibility of magnesium deficiency in paraplegia.
PATIENTS AND METHODS
Two groups of patients were studied. Group I consisted of 16 traumatic paraplegics (13 male and 3 female) admitted within 5 days of spinal cord injury (Table I ). The total urinary output of the male patients was collected daily for a minimum of 3 weeks and of the female patients until they began to pass urine spontaneously. The urines were analysed for calcium, magnesium, sodium, potassium, inorganic phosphate, creatinine and in some patients nitrogen. Venous blood was taken at intervals of 3-4 days for the estimation of calcium, magnesium, sodium and potassium.
Group 2 consisted of ten other patients with traumatic paraplegias of varying duration, showing symptoms suggestive of magnesium deficiency (Table II) . Blood was taken at this time for the estimation of calcium and magnesium.
Calcium and magnesium were measured by atomic absorption spectrophoto metry, sodium and potassium by flame photometry, inorganic phosphate and creatinine by the autoanalyser (Technicon Ltd.). The urinary nitrogen was estimated as follows: I ml. of a I in 1000 dilution of urine was mixed with I ml. of a solution containing 2 g. Se02 and 70 ml. concentrated H2S04• After digestion, 2 ml. of a solution containing 15 g. phenol and 0·075 g. sodium nitroprusside per litre were added, followed by 4 ml. of a solution containing 35·8 g. Na2HP04 I2H20, 17·5 g. NaOH and 0 . 317 g. NaOCl per litre. After 30 minutes extinctions were read at 625 nm. The 16 patients in Group I showed an increased excretion of magnesium, potassium and inorganic phosphate which reached a maximum between the 5th and 15th day then declined to a constant level within the normal range. Four of the 16 patients showed an elevated serum magnesium for a period of, 1,6,8 and 10 days respectively, which corresponded with the period of increased urinary excretion. The serum and urinary magnesium on one of these patients are shown in Figure I .
A serum magnesium level below the limit of normal (1'4 mEq./l.) was observed on one occasion in two of the 16 patients ( fig. 2 ). One of these (K. W.) had a transient dip (1'25 mEq./l.) corresponding to the peak in urinary excretion, and the other (W. C.) showed a shallow depression, the lowest point of which (1'35 mEq./l.) coincided with a low serum sodium. No urine results were available from this patient because she was by this time incontinent. Another patient (D. B. in Table I ) was pregnant and nearing term at the time of injury. Delivery (stillbirth) on the 6th day was accompanied by an abrupt fall in serum magnesium from 2'0 mEq./l. to 1"4 mEq./l. and a rise in urinary magnesium ( fig. 3) . The remaining nine patients had a normal serum magnesium throughout the whole period of the investigation.
There was a statistically significant correlation (P < 0'05) between magnesium 
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Serum and urinary magnesium levels in one of the patients with a transiently elevated serum magnesium. Urinary excretion of magnesium, phosphorus, potassium, nitrogen and calcium in a selection of the patients studied.
and phosphate excretion in eight of the 16 patients; two of the 16 showed a significant correlation between magnesium and potassium excretion (P < 0·05) and seven between potassium and phosphate excretion (P < 0·05). The patterns of excretion found in three patients taken as representative are shown in Figure 4 . There was no correlation between the urinary magnesium and the urinary sodium/potassium ratio in any patient (P > 0·05).
The urinary calcium showed a more or less steady increase for the first 10-30 days of paraplegia ( fig. 4) . One patient (F. D.) on whom the study was continued for 60 days showed a delayed increase which did not commence until the 45th day. Another patient (A. ].), aged 66, had a very low urinary calcium until the 30th day, when there was a small increase ( fig. 4) . There was no consistent pattern of sodium excretion. Eight of the 10 patients in Group 2 had serum magnesium levels within the normal range, the other two had slightly elevated levels (Table II) .
DISCUSSION
A constant feature of the present series was the increased urinary magnesium lasting from 5 to 10 days during the first 30 days following injury to the spinal cord. Other workers have reported that trauma is followed by increased blood and urinary magnesium (Beecher et al., 1947; Gillette et al., 1958; Walker et al., 1968) suggesting that the excretion of magnesium is secondary to its release from traumatised or atrophied cells. The parallel behaviour of urinary nitrogen, potassium and phosphate supports this conclusion.
The hypomagnesaemia found in two patients was transient and insufficient to produce symptoms. This contrasts with the prolonged fall in serum magnesium, in some cases to below 1·0 mEq./l., observed in patients with burns (Broughton et al., 1968) . The abrupt fall of serum magnesium seen in patient D. B. (fig. 3 ) was unlikely to have been due to urinary loss because it coincided with, rather than followed, the increased urinary magnesium, and was probably associated with redistribution between the magnesium compartments. Hypomagnesaemia has previously been reported in parturition (Wallach et al., 1962) but no explanation was offered.
An increased excretion of aldosterone accompanies the sodium retention and potassium loss which follow surgery, and Llaurado (1957) suggested the use of the urinary potassium/sodium ratio as an index of aldosterone release. However, there is evidence that these phenomena are unrelated (Gowenlock & Longson, 1970) . Information relating to the effect of aldosterone on the renal handling of magnesium is conflicting. Horton and Biglieri (1962) , studying patients with primary aldo steronism and also adrenalectomised patients, found that aldosterone increased the output of magnesium in the urine, but Lemann et al. (1970) found that neither aldosterone nor cortisol influenced the urinary excretion of magnesium in healthy man. Therefore it is not surprising that the present results reveal no correlation between the urinary magnesium and the sodium/potassium ratio.
Sixty-three per cent. of the total body magnesium is found in bone (Aikawa� 1964) and the increase in urinary calcium observed in paraplegics is known to be derived from bone (Chantraine, 1971) . However, the increase in urinary magnesium following paraplegia is too large to be derived only from bone because the molar ratio of magnesium to calcium in bone is very small (1:50) (Fraser & McIntyre, K 1970) . The increases of urinary magnesium, phosphate, potassium and nitrogen ( fig. 4) were in the proportions expected from skeletal muscle (Diem, 1962) , but metabolic balance studies will be required to confirm this relationship.
Thus the increased urinary magnesium which follows the onset of paraplegia is probably related mainly to the increased load presented for excretion, which is derived from the catabolic response to trauma and the muscle wasting that results from paralysis.
The symptoms observed in the patients of Group 2 are unexplained but were not due to magnesium deficiency.
SUMMARY
Serial measurements of serum and urinary magnesium in 16 acute traumatic paraplegic patients revealed a period of increased urinary excretion of magnesium in all, associated in four of them with an elevated serum magnesium, and in two with transient hypomagnesaemia.
In ten other patients showing symptoms suggestive of magnesium deficiency the serum magnesium was within normal limits in eight, and elevated in two.
There is no evidence that magnesium deficiency is responsible for symptoms in paraplegia.
RESUME
Le dosage du taux de magnesium sanguin et urinaire a ete effectue chez 16 paraplegiques post-traumatiques au cours de la periode aigue. Dne augmentation du taux du magnesium dans l'urine a ete notee chez tous, associee dans 4 cas avec une augmentation du magnesium serique et dans 2 cas avec une diminution du taux serique, transitoire.
Chez IO autres malades presentant des symptomes pouvant se reporter a une deficience en magnesium, Ie taux serique de celui-ci a ete normal dans 8 cas et augmente dans les 2 autres cas. Il n'y a pas d'evidence qu'une deficience en magnesium puisse etre symptomatique chez Ie paraplegique. 
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